BeFreed
    Categories>Well-Being>Why Give Xgeva After Ibrance? Medical Guide for Students

    Why Give Xgeva After Ibrance? Medical Guide for Students

    22 min
    |
    |
    15. Apr. 2026
    Well-BeingTechnologyEducation

    Explore the clinical rationale for using Xgeva after Ibrance in metastatic breast cancer. A medical guide on managing bone metastases and RANKL inhibition.

    Why Give Xgeva After Ibrance? Medical Guide for Students

    Bestes Zitat aus Why Give Xgeva After Ibrance? Medical Guide for Students

    “

    Unlike bisphosphonates, which must be incorporated into the bone matrix to function, denosumab acts as a circulating monoclonal antibody that mimics osteoprotegerin, essentially turning off the faucet of osteoclastogenesis. However, because its effect is entirely reversible, clinicians must manage the 'rebound phenomenon' with a bisphosphonate bridge to prevent rapid bone loss and spontaneous fractures upon discontinuation.

    ”
    A

    Generated by Ahmed Obaid

    Eingabefrage

    why giving xgeva after ibrance?. Make sure to focus on scientifically proven and accurate info and make the lesson towards medical students.

    Moderatorstimmen
    Jacksonplay
    Wissensquellen
    Undying
    Emperor of All Maladies
    Being Mortal
    Cancer Journals
    Ten Drugs
    Dr. Patrick Walsh's Guide to Surviving Prostate Cancer

    Häufig gestellte Fragen

    In the context of metastatic breast cancer, Ibrance (palbociclib) functions as a CDK4/6 inhibitor to arrest the cell cycle, while Xgeva (denosumab) is introduced to manage bone metastases. Medical students should understand that while Ibrance targets systemic tumor progression, Xgeva acts as a RANKL inhibitor to prevent skeletal-related events. This sequential or concurrent approach ensures that while the primary malignancy is being treated, the structural integrity of the skeletal system is protected from osteoclast-mediated bone destruction.

    Denosumab, the active agent in Xgeva, is a human monoclonal antibody that binds to RANKL, a protein essential for the formation and survival of osteoclasts. In patients previously or currently treated with Ibrance for metastatic disease, bone resorption is a significant risk. By inhibiting RANKL, Xgeva reduces bone turnover and the incidence of fractures. For students of oncology pharmacology, this represents a targeted supportive therapy that works alongside cytostatic treatments to improve patient quality of life and skeletal stability.

    Bone is one of the most common sites for breast cancer metastasis, often leading to pathological fractures, spinal cord compression, and hypercalcemia. While Ibrance focuses on extending progression-free survival by inhibiting cyclin-dependent kinases, it does not directly mitigate bone-specific damage. Therefore, integrating a bone-modifying agent like Xgeva is essential. This dual strategy addresses both the proliferation of the adenocarcinoma and the secondary complications arising within the bone microenvironment, which is a standard of care in advanced oncological management.

    Von Columbia University Alumni in San Francisco entwickelt

    BeFreed vereint eine globale Gemeinschaft von 1,000,000 wissbegierigen Menschen
    Erfahren Sie mehr darüber, wie BeFreed im Web diskutiert wird

    "Instead of endless scrolling, I just hit play on BeFreed. It saves me so much time."

    @Moemenn
    platform
    star
    star
    star
    star
    star

    "I never knew where to start with nonfiction—BeFreed’s book lists turned into podcasts gave me a clear path."

    @Chloe, Solo founder, LA
    platform
    comments
    12
    likes
    117

    "Perfect balance between learning and entertainment. Finished ‘Thinking, Fast and Slow’ on my commute this week."

    @Raaaaaachelw
    platform
    star
    star
    star
    star
    star

    "Crazy how much I learned while walking the dog. BeFreed = small habits → big gains."

    @Matt, YC alum
    platform
    comments
    12
    likes
    108

    "Reading used to feel like a chore. Now it’s just part of my lifestyle."

    @Erin, Investment Banking Associate , NYC
    platform
    comments
    254
    likes
    17

    "Feels effortless compared to reading. I’ve finished 6 books this month already."

    @djmikemoore
    platform
    star
    star
    star
    star
    star

    "BeFreed turned my guilty doomscrolling into something that feels productive and inspiring."

    @Pitiful
    platform
    comments
    96
    likes
    4.5K

    "BeFreed turned my commute into learning time. 20-min podcasts are perfect for finishing books I never had time for."

    @SofiaP
    platform
    star
    star
    star
    star
    star

    "BeFreed replaced my podcast queue. Imagine Spotify for books — that’s it. 🙌"

    @Jaded_Falcon
    platform
    comments
    201
    thumbsUp
    16

    "It is great for me to learn something from the book without reading it."

    @OojasSalunke
    platform
    star
    star
    star
    star
    star

    "The themed book list podcasts help me connect ideas across authors—like a guided audio journey."

    @Leo, Law Student, UPenn
    platform
    comments
    37
    likes
    483

    "Makes me feel smarter every time before going to work"

    @Cashflowbubu
    platform
    star
    star
    star
    star
    star

    Von Columbia University Alumni in San Francisco entwickelt

    BeFreed vereint eine globale Gemeinschaft von 1,000,000 wissbegierigen Menschen
    Erfahren Sie mehr darüber, wie BeFreed im Web diskutiert wird

    "Instead of endless scrolling, I just hit play on BeFreed. It saves me so much time."

    @Moemenn
    platform
    star
    star
    star
    star
    star

    "I never knew where to start with nonfiction—BeFreed’s book lists turned into podcasts gave me a clear path."

    @Chloe, Solo founder, LA
    platform
    comments
    12
    likes
    117

    "Perfect balance between learning and entertainment. Finished ‘Thinking, Fast and Slow’ on my commute this week."

    @Raaaaaachelw
    platform
    star
    star
    star
    star
    star

    "Crazy how much I learned while walking the dog. BeFreed = small habits → big gains."

    @Matt, YC alum
    platform
    comments
    12
    likes
    108

    "Reading used to feel like a chore. Now it’s just part of my lifestyle."

    @Erin, Investment Banking Associate , NYC
    platform
    comments
    254
    likes
    17

    "Feels effortless compared to reading. I’ve finished 6 books this month already."

    @djmikemoore
    platform
    star
    star
    star
    star
    star

    "BeFreed turned my guilty doomscrolling into something that feels productive and inspiring."

    @Pitiful
    platform
    comments
    96
    likes
    4.5K

    "BeFreed turned my commute into learning time. 20-min podcasts are perfect for finishing books I never had time for."

    @SofiaP
    platform
    star
    star
    star
    star
    star

    "BeFreed replaced my podcast queue. Imagine Spotify for books — that’s it. 🙌"

    @Jaded_Falcon
    platform
    comments
    201
    thumbsUp
    16

    "It is great for me to learn something from the book without reading it."

    @OojasSalunke
    platform
    star
    star
    star
    star
    star

    "The themed book list podcasts help me connect ideas across authors—like a guided audio journey."

    @Leo, Law Student, UPenn
    platform
    comments
    37
    likes
    483

    "Makes me feel smarter every time before going to work"

    @Cashflowbubu
    platform
    star
    star
    star
    star
    star

    "Instead of endless scrolling, I just hit play on BeFreed. It saves me so much time."

    @Moemenn
    platform
    star
    star
    star
    star
    star

    "I never knew where to start with nonfiction—BeFreed’s book lists turned into podcasts gave me a clear path."

    @Chloe, Solo founder, LA
    platform
    comments
    12
    likes
    117

    "Perfect balance between learning and entertainment. Finished ‘Thinking, Fast and Slow’ on my commute this week."

    @Raaaaaachelw
    platform
    star
    star
    star
    star
    star

    "Crazy how much I learned while walking the dog. BeFreed = small habits → big gains."

    @Matt, YC alum
    platform
    comments
    12
    likes
    108

    "Reading used to feel like a chore. Now it’s just part of my lifestyle."

    @Erin, Investment Banking Associate , NYC
    platform
    comments
    254
    likes
    17

    "Feels effortless compared to reading. I’ve finished 6 books this month already."

    @djmikemoore
    platform
    star
    star
    star
    star
    star

    "BeFreed turned my guilty doomscrolling into something that feels productive and inspiring."

    @Pitiful
    platform
    comments
    96
    likes
    4.5K

    "BeFreed turned my commute into learning time. 20-min podcasts are perfect for finishing books I never had time for."

    @SofiaP
    platform
    star
    star
    star
    star
    star

    "BeFreed replaced my podcast queue. Imagine Spotify for books — that’s it. 🙌"

    @Jaded_Falcon
    platform
    comments
    201
    thumbsUp
    16

    "It is great for me to learn something from the book without reading it."

    @OojasSalunke
    platform
    star
    star
    star
    star
    star

    "The themed book list podcasts help me connect ideas across authors—like a guided audio journey."

    @Leo, Law Student, UPenn
    platform
    comments
    37
    likes
    483

    "Makes me feel smarter every time before going to work"

    @Cashflowbubu
    platform
    star
    star
    star
    star
    star

    "Instead of endless scrolling, I just hit play on BeFreed. It saves me so much time."

    @Moemenn
    platform
    star
    star
    star
    star
    star

    "I never knew where to start with nonfiction—BeFreed’s book lists turned into podcasts gave me a clear path."

    @Chloe, Solo founder, LA
    platform
    comments
    12
    likes
    117

    "Perfect balance between learning and entertainment. Finished ‘Thinking, Fast and Slow’ on my commute this week."

    @Raaaaaachelw
    platform
    star
    star
    star
    star
    star

    "Crazy how much I learned while walking the dog. BeFreed = small habits → big gains."

    @Matt, YC alum
    platform
    comments
    12
    likes
    108

    "Reading used to feel like a chore. Now it’s just part of my lifestyle."

    @Erin, Investment Banking Associate , NYC
    platform
    comments
    254
    likes
    17

    "Feels effortless compared to reading. I’ve finished 6 books this month already."

    @djmikemoore
    platform
    star
    star
    star
    star
    star

    "BeFreed turned my guilty doomscrolling into something that feels productive and inspiring."

    @Pitiful
    platform
    comments
    96
    likes
    4.5K

    "BeFreed turned my commute into learning time. 20-min podcasts are perfect for finishing books I never had time for."

    @SofiaP
    platform
    star
    star
    star
    star
    star

    "BeFreed replaced my podcast queue. Imagine Spotify for books — that’s it. 🙌"

    @Jaded_Falcon
    platform
    comments
    201
    thumbsUp
    16

    "It is great for me to learn something from the book without reading it."

    @OojasSalunke
    platform
    star
    star
    star
    star
    star

    "The themed book list podcasts help me connect ideas across authors—like a guided audio journey."

    @Leo, Law Student, UPenn
    platform
    comments
    37
    likes
    483

    "Makes me feel smarter every time before going to work"

    @Cashflowbubu
    platform
    star
    star
    star
    star
    star
    1.5K Ratings4.7
    Starten Sie Ihre Lernreise, jetzt
    BeFreed App
    BeFreed

    Lernen Sie alles, personalisiert

    DiscordLinkedIn
    Empfohlene Buchzusammenfassungen
    Crucial ConversationsThe Perfect MarriageInto the WildNever Split the DifferenceAttachedGood to GreatSay Nothing
    Trendkategorien
    Self HelpCommunication SkillRelationshipMindfulnessPhilosophyInspirationProductivity
    Leselisten von Prominenten
    Elon MuskCharlie KirkBill GatesSteve JobsAndrew HubermanJoe RoganJordan Peterson
    Preisgekrönte Sammlung
    Pulitzer PrizeNational Book AwardGoodreads Choice AwardsNobel Prize in LiteratureNew York TimesCaldecott MedalNebula Award
    Empfohlene Themen
    ManagementAmerican HistoryWarTradingStoicismAnxietySex
    Beste Bücher nach Jahr
    2025 Best Non Fiction Books2024 Best Non Fiction Books2023 Best Non Fiction Books
    Empfohlene Autoren
    Chimamanda Ngozi AdichieGeorge OrwellO. J. SimpsonBarbara O'NeillWinston ChurchillCharlie Kirk
    BeFreed vs. andere Apps
    BeFreed vs. Other Book Summary AppsBeFreed vs. ElevenReaderBeFreed vs. ReadwiseBeFreed vs. Anki
    Lernwerkzeuge
    Knowledge VisualizerAI Podcast Generator
    Informationen
    Über unsarrow
    Preisearrow
    FAQarrow
    Blogarrow
    Karrierearrow
    Partnerschaftenarrow
    Botschafter-Programmarrow
    Verzeichnisarrow
    BeFreed
    Try now
    © 2026 BeFreed
    NutzungsbedingungenDatenschutzrichtlinie
    BeFreed

    Lernen Sie alles, personalisiert

    DiscordLinkedIn
    Empfohlene Buchzusammenfassungen
    Crucial ConversationsThe Perfect MarriageInto the WildNever Split the DifferenceAttachedGood to GreatSay Nothing
    Trendkategorien
    Self HelpCommunication SkillRelationshipMindfulnessPhilosophyInspirationProductivity
    Leselisten von Prominenten
    Elon MuskCharlie KirkBill GatesSteve JobsAndrew HubermanJoe RoganJordan Peterson
    Preisgekrönte Sammlung
    Pulitzer PrizeNational Book AwardGoodreads Choice AwardsNobel Prize in LiteratureNew York TimesCaldecott MedalNebula Award
    Empfohlene Themen
    ManagementAmerican HistoryWarTradingStoicismAnxietySex
    Beste Bücher nach Jahr
    2025 Best Non Fiction Books2024 Best Non Fiction Books2023 Best Non Fiction Books
    Lernwerkzeuge
    Knowledge VisualizerAI Podcast Generator
    Empfohlene Autoren
    Chimamanda Ngozi AdichieGeorge OrwellO. J. SimpsonBarbara O'NeillWinston ChurchillCharlie Kirk
    BeFreed vs. andere Apps
    BeFreed vs. Other Book Summary AppsBeFreed vs. ElevenReaderBeFreed vs. ReadwiseBeFreed vs. Anki
    Informationen
    Über unsarrow
    Preisearrow
    FAQarrow
    Blogarrow
    Karrierearrow
    Partnerschaftenarrow
    Botschafter-Programmarrow
    Verzeichnisarrow
    BeFreed
    Try now
    © 2026 BeFreed
    NutzungsbedingungenDatenschutzrichtlinie

    Kernaussagen

    1

    Defending the Skeleton After CDK4/6 Inhibition

    0:00
    2

    Theoretical Foundations of the Estrogen Bone Axis

    0:54
    3

    Comparative Pharmacology and the Choice of Potency

    3:29
    4

    The Synergistic Potential with Immunotherapy

    6:06
    5

    Managing the Rebound Phenomenon and Risk of Withdrawal

    8:33
    6

    Molecular Insights from Transgenic Models

    10:56
    7

    Resistance Mechanisms and the CDK4/6 Bypass

    13:15
    8

    Navigating the Post-Progression Therapeutic Landscape

    15:42
    9

    The Practical Playbook for Clinical Rotations

    17:58
    10

    Reflection on the Continuum of Skeletal Care

    20:06

    Mehr davon

    Buchcover von Brukinsa vs Calquence: Why the Single Drug May Win
    Emperor of All MaladiesElegant Defense : The Extraordinary New Science of the Immune SystemEvery Patient Tells a StoryEvery Patient Tells a Story
    21 sources
    Brukinsa vs Calquence: Why the Single Drug May Win
    Choosing between CLL treatments is getting harder. We compare recent data on Brukinsa and Calquence to see which BTK inhibitor offers better survival.
    13 min
    Buchcover von Tagrisso vs Rybrevant: Is one extra year worth the risk?
    How to Read a PaperEmperor of All MaladiesSummary of Annette Bosworth's ANYWAY YOU CANEvery Patient Tells a Story
    24 sources
    Tagrisso vs Rybrevant: Is one extra year worth the risk?
    New MARIPOSA data shows a survival gap in EGFR lung cancer treatment. Learn how to weigh drug efficacy against side effects for better patient outcomes.
    28 min
    Buchcover von Erbitux vs Vectibix: Which EGFR Inhibitor Wins?
    Emperor of All MaladiesHow to Read a PaperElegant Defense : The Extraordinary New Science of the Immune SystemThe Immortal Life of Henrietta Lacks
    23 sources
    Erbitux vs Vectibix: Which EGFR Inhibitor Wins?
    Choosing between cetuximab and panitumumab is tricky. We break down new JSCCR data on survival rates and molecular differences to help you decide.
    28 min
    Buchcover von Strensiq: Reversing Hypercalcemia in Hypophosphatasia Patients
    Bone turnover and mineral metabolism in adult patients with hypophosphatasia treated with asfotase alfaEffectiveness of asfotase alfa for treatment of adults with ... - NIHEfficacy and safety of asfotase alfa in patients with hypophosphatasia: A systematic review - PubMedProfile of asfotase alfa in the treatment of hypophosphatasia: design, development, and place in therapy
    6 sources
    Strensiq: Reversing Hypercalcemia in Hypophosphatasia Patients
    Discover how enzyme replacement therapy with Strensiq addresses the root cause of hypercalcemia in HPP by restoring bone mineralization. Learn why this isn't about restricting calcium-it's about helping bones use it effectively.
    9 min
    Buchcover von Neupogen vs Neulasta: Why PEGylation Matters
    Saunders comprehensive review for the NCLEX-RN examinationStem cellsNine PintsTen Drugs
    21 sources
    Neupogen vs Neulasta: Why PEGylation Matters
    Struggling to remember G-CSF dosing? Learn how PEGylation and neutrophil-mediated clearance differentiate filgrastim from pegfilgrastim for clinical use.
    35 min
    Buchcover von New Frontiers in Anticoagulation Care
    First AHA/ACC acute pulmonary embolism guideline: prompt diagnosis and treatment are key - American College of Cardiology2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM/SVN ...COBRRA: Bleeding Risk Lower With Apixaban Than Rivaroxaban in VTE at 3 Months - American College of CardiologyCHAMPION-AF: Left Atrial Appendage Closure vs. Anticoagulation For AFib - American College of Cardiology
    8 sources
    New Frontiers in Anticoagulation Care
    Old risk labels are changing. Learn how the 2026 guidelines and Factor XIa inhibitors are making stroke prevention safer and hospital stays shorter.
    12 min
    Buchcover von Ramucirumab: Cutting the Tumor Supply Line
    Mechanism, Clinical Applications, and Biosimilars in Cancer ResearchTargeted inhibition of VEGF Receptor-2: An update on RamucirumabOTT-80239-profile-of-ramucirumab-in-the-treatment-of-metastatic-non-smsource 4
    4 sources
    Ramucirumab: Cutting the Tumor Supply Line
    Tumors build private blood vessel networks to grow. Learn how ramucirumab targets the VEGFR-2 receptor to starve cancer and improve patient outcomes.
    15 min
    Buchcover von Apalutamide vs Abiraterone for Prostate Cancer
    Dr. Patrick Walsh's Guide to Surviving Prostate CancerThe Testosterone Optimization Therapy BibleEmperor of All MaladiesHow to Read a Paper
    20 sources
    Apalutamide vs Abiraterone for Prostate Cancer
    Since head-to-head trials are missing, how do you choose between these therapies? Compare real-world data and PSA responses to guide clinical decisions.
    41 min

    Recommended Learning Plans

    The Atorvastatin Decision Guide
    LERNPLAN

    The Atorvastatin Decision Guide

    This guide is essential for patients and caregivers navigating cholesterol management and cardiovascular health. It provides a balanced look at the science and practicalities of Atorvastatin to empower informed healthcare decisions.

    1 h 15 m•3 Abschnitte
    Corticosteroids: From Molecular Mechanism to Bedside
    LERNPLAN

    Corticosteroids: From Molecular Mechanism to Bedside

    This plan bridges the gap between basic endocrine science and clinical application, providing a comprehensive look at steroid therapy. It is essential for medical students and clinicians seeking to optimize drug selection while minimizing systemic toxicity.

    2 h•4 Abschnitte
    Starting glp
    LERNPLAN

    Starting glp

    This plan provides a comprehensive roadmap for individuals considering or beginning GLP-1 therapy. It is essential for patients and health-conscious individuals who want to combine clinical treatment with sustainable lifestyle integration.

    3 h 25 m•4 Abschnitte
    Gatekeepers of Adenosine Flux
    LERNPLAN

    Gatekeepers of Adenosine Flux

    This learning plan provides a deep dive into the molecular regulation of adenosine, a critical signaling molecule in inflammation and oncology. It is ideal for researchers, pharmacologists, and clinicians looking to master the therapeutic potential of Equilibrative Nucleoside Transporters.

    1 h 30 m•3 Abschnitte
    Pronóstico oncológico de precisión en UCI
    LERNPLAN

    Pronóstico oncológico de precisión en UCI

    Este plan de aprendizaje es fundamental para intensivistas y oncólogos que buscan actualizarse en el manejo del paciente crítico con cáncer. Aborda la transición de modelos estadísticos genéricos a un enfoque personalizado basado en biomarcadores y nuevas terapias.

    1 h 12 m•3 Abschnitte
    Leigh's Endocrine & NCCAH Education Guide
    LERNPLAN

    Leigh's Endocrine & NCCAH Education Guide

    This guide bridges the gap between conventional clinical endocrinology and evidence-based complementary therapies. It is designed for healthcare professionals and students seeking a holistic yet scientifically rigorous approach to managing hormonal health and complex metabolic conditions.

    4 h 9 m•4 Abschnitte
    AI 驱动的药物研发与老药新用
    LERNPLAN

    AI 驱动的药物研发与老药新用

    随着生物医药数据爆炸式增长,AI 已成为加速药物研发和老药新用的核心引擎。本课程专为生物信息学研究者和药企研发人员设计,旨在打通从数据建模到临床验证的全链路,解决 AI 模型“黑箱”与落地难的痛点。

    1 h 30 m•3 Abschnitte
    Oxford med studies: gyn focus
    LERNPLAN

    Oxford med studies: gyn focus

    This learning plan provides comprehensive training in gynecological medicine, essential for medical students, residents, and clinicians seeking specialized expertise in women's health. It addresses critical gaps in medical education by combining foundational anatomy with advanced reproductive medicine, clinical reasoning, and current research in gynecology.

    5 h 3 m•4 Abschnitte